Costantino,Paolo

Institution: Novartis Vaccines Institute for Global Health, Italy

Research Interests: Oligosaccharides, Antibodies, Vaccines, Mice, Conjugate Vaccines, Disease, Animal, Antigen, Antigens, Antisera, Igg, Mannose, Glycoconjugates, Infections, Strains, Epidemic, Meningitis, Electrical Stimulation, Evoked Potentials, Motor Evoked Potentials

Information and abstracts for author publications
Published Date	Impact	Publication
11/04/2013	9.8	Proceedings of the National Academy of Sciences of the United States of America Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.	Abstract
06/07/2012	6.4	ACS chemical biology Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide.	Abstract
07/18/2009	3.8	Vaccine Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages.	Abstract
09/24/2010	3.8	Vaccine Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate.	Abstract
08/22/2012	3.8	Vaccine Relative stability of meningococcal serogroup A and X polysaccharides.	Abstract
01/10/2009	3.4	Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology Methodology for intraoperatively eliciting motor evoked potentials in the vocal muscles by electrical stimulation of the corticobulbar tract.	Abstract
06/04/2010	2.1	Glycoconjugate journal Preparation, characterization and immunogenicity of HIV-1 related high-mannose oligosaccharides-CRM197 glycoconjugates.	Abstract